Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
30.52
+0.97 (3.28%)
At close: Jun 26, 2026, 4:00 PM EDT
30.07
-0.45 (-1.47%)
After-hours: Jun 26, 2026, 6:06 PM EDT
Sutro Biopharma Employees
Sutro Biopharma had 133 employees as of March 31, 2026. The number of employees decreased by 4 or -2.92% since the number was last reported on December 31, 2025.
Employees
133
Change
-4
Growth
-2.92%
Revenue / Employee
$748,932
Profits / Employee
-$1,154,902
Market Cap
505.73M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| ProKidney | 231 |
| Cabaletta Bio | 158 |
| Neurogene | 131 |
| Kyverna Therapeutics | 129 |
| Ocugen | 116 |
| C4 Therapeutics | 104 |
| Silence Therapeutics | 88 |
STRO News
- 16 days ago - Sutro Biopharma assumed with a Buy at Truist - TheFly
- 22 days ago - Sutro Biopharma Transcript: AGM 2026 - Transcripts
- 23 days ago - Sutro Biopharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Sutro Biopharma initiated with an Overweight at Barclays - TheFly
- 4 weeks ago - Sutro Biopharma Transcript: 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA - Transcripts
- 5 weeks ago - Sutro Biopharma price target raised to $10 from $9 at BofA - TheFly
- 6 weeks ago - Wedbush upgrades Sutro Biopharma to Outperform, raises price target to $60 - TheFly
- 6 weeks ago - Sutro Biopharma upgraded to Outperform from Neutral at Wedbush - TheFly